معرفی
Richard A Bernstein serves as Professor of Neurology specializing in Stroke and Vascular Neurology at Northwestern University's Feinberg School of Medicine. He maintains clinical affiliations with Northwestern Medicine, Kishwaukee Hospital, and Northwestern Memorial Hospital, providing expertise in neurovascular critical care and complex stroke cases.
His educational foundation includes:
- PhD from The Rockefeller University (1995)
- MD from Cornell Weill Medical College (1996)
- Medicine Internship at Mount Sinai Hospital, Illinois (1997)
- Neurology Residency at New York Presbyterian Hospital (2000)
- Fellowship at University of California-San Francisco Medical Center (2001)
Dr. Bernstein's research centers on stroke pathophysiology and innovative treatments, with particular focus on stroke of unknown cause, atrial fibrillation detection in cryptogenic stroke, and novel anticoagulation strategies. His work bridges clinical practice and translational research through stem cell therapy investigations and acute intervention protocols for young stroke patients.
Analysis of his 2023-2024 publications reveals consistent emphasis on secondary stroke prevention through improved cardiac monitoring (STROKE AF trial) and next-generation anticoagulants (AXIOMATIC-SSP trial). Key themes include optimizing atrial fibrillation detection in non-lacunar stroke patients and developing safer anticoagulation approaches via factor XIa inhibition.
He actively contributes to clinical research as:
- Current member of CAPTIVA trial (2022-present)
- Consultant for Bristol Myers Squibb and Pfizer (2019-present)
- Editorial Board Member of Stroke journal (2023-present)
